This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 May;57(5):991-2.

doi: 10.3109/10428194.2015.1092531. Epub 2015 Oct 13.

Lymphoplasmacytic lymphoma: What we need to know

Rajshekar Chakraborty¹, Morie A Gertz¹

Affiliations

PMID: 26374283
DOI: 10.3109/10428194.2015.1092531

Comment

Lymphoplasmacytic lymphoma: What we need to know

Rajshekar Chakraborty et al. Leuk Lymphoma. 2016 May.

. 2016 May;57(5):991-2.

doi: 10.3109/10428194.2015.1092531. Epub 2015 Oct 13.

Authors

Rajshekar Chakraborty¹, Morie A Gertz¹

Affiliation

¹ a Hematology, Mayo Clinic , Rochester , MN , USA.

PMID: 26374283
DOI: 10.3109/10428194.2015.1092531

No abstract available

PubMed Disclaimer

Comment on

Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression.
Cao X, Medeiros LJ, Xia Y, Wang X, Thomas SK, Loghavi S, Li X, Shah JJ, Gustafson SA, Weber DM, Miranda RN, Xu-Monette ZY, Orlowski RZ, Young KH. Cao X, et al. Leuk Lymphoma. 2016 May;57(5):1104-13. doi: 10.3109/10428194.2015.1096357. Epub 2015 Dec 23. Leuk Lymphoma. 2016. PMID: 26421453

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon